首页|噬菌体制剂应用及不同国家的审批情况

噬菌体制剂应用及不同国家的审批情况

扫码查看
全球耐药菌问题日趋严峻,严重威胁着人类和动物的生命健康.噬菌体可以专一地靶向杀灭有害菌而不会产生细菌耐药性问题,是解决全球耐药菌问题的有效途径.虽然噬菌体的研究已有百年历史,但是我国噬菌体制剂的应用仍处在摸索状态.本文总结了噬菌体制剂目前在人类和动物细菌性疾病的预防、治疗和环境消毒等方面应用现状,同时也搜集了噬菌体研究前沿国家的噬菌体制剂审批情况,希望可以有效推动噬菌体制剂在更多领域的应用.
Overview of the Application and Approval Status of Bacteriophage Preparations in Different Countries
The global problem of drug-resistant bacteria is becoming increasingly severe,posing a serious threat to the lives and health of humans and animals.Phages can specifically target and kill harmful bacteria without causing bacterial resistance issues,which is an effective way to solve the global problem of drug-resistant bacteria.Although the research on bacteriophages has a hundred years of history,the application of bacteriophage preparations in China is still in a state of exploration.This article summarizes the current application status of bacteriophage preparations in the prevention,treatment,and environmental disinfection of human and animal bacterial diseases,and also collects the approval status of bacteriophage preparations from different countries at the forefront of bacteriophage research.In this way,we can effectively promote the application of bacteriophage preparations in various fields and promote the approval and application of bacteriophage preparations in China.

phage therapyapplicationsbacteriophage preparationsregistration for approval

庄盈婷、孙虎芝、闫艳新、刘广芹、赵鹏、张召佐、于凌云、刘建兴、赵飞扬、潘强、任慧英

展开 >

青岛诺安百特生物技术有限公司,山东青岛266109

北京诺安百汇医药科技有限公司,北京100085

浙江诺安生物技术有限公司,浙江温州325800

噬菌体治疗 应用 噬菌体制剂 注册审批

2024

中国兽药杂志
中国兽医药品监察所

中国兽药杂志

CSTPCD
影响因子:0.49
ISSN:1002-1280
年,卷(期):2024.58(12)